|
"Mechanisms of Damage-Induced Homologous Recombination"
|
5R01CA079827-09
|
$232,412
|
$232,412
|
ENGELWARD, BEVIN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
"Starve the Tumor Cells to Death": SLC6A14 as a Drug Target for Colon Cancer
|
5R21CA152396-02
|
$155,068
|
$155,068
|
GANAPATHY, VADIVEL
|
GEORGIA HEALTH SCIENCES UNIV RES INSTIT
|
|
15-LOX-1 effects on colitis and colon cancer
|
4R01CA137213-03
|
$309,964
|
$309,964
|
SHUREIQI, IMAD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
15-PGDH, A Novel in Vivo Suppressor of Colon Neoplasia in Mouse and Man
|
5R01CA127306-05
|
$424,594
|
$424,594
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
2-Amino-9H-pyrido[2,3-b]indole: a potential colorectal carcinogen formed in tobac
|
5R01CA134700-02
|
$288,938
|
$288,938
|
Turesky, Robert
|
WADSWORTH CENTER
|
|
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
|
5R01CA129484-04
|
$381,417
|
$190,709
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
A Center for the Convergence of Physical Science and Cancer Biology
|
4U54CA143862-03
|
$1,715,390
|
$1,715,390
|
Davies, Paul
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
A Follow-up Study for Causes of Illness in Black Women
|
5R01CA058420-18
|
$1,716,010
|
$858,005
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Genetic Screen for HCC Genes
|
5R01CA132962-02
|
$302,919
|
$302,919
|
LARGAESPADA, DAVID
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
A Mediterranean Diet in for Colon Cancer Prevention
|
5R01CA120381-05
|
$287,805
|
$287,805
|
DJURIC, ZORA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
A Method to Direct the Human Immune System Against Metastatic Cancer Cells
|
1F32CA144383-01A1
|
$48,398
|
$48,398
|
Jakobsche, Charles
|
YALE UNIVERSITY
|
|
A Model for Preclinical Biomarker Discovery in Pancreatic Ductal Adenocarcinoma
|
5K08CA137153-02
|
$163,080
|
$163,080
|
Collisson, Eric
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
A mouse model for human gastrointestinal stromal tumor
|
5R01CA102774-07
|
$398,292
|
$398,292
|
BESMER, PETER
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
|
5R01CA125231-05
|
$284,400
|
$68,256
|
RAMSEY, SCOTT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A Multidisciplinary and Translational Approach to Hepatobiliary Malignancy
|
5K24CA139570-02
|
$186,940
|
$186,940
|
Nelson, David
|
UNIVERSITY OF FLORIDA
|
|
A New Method for Improved Targeting in Image-guided Abdominal Interventions
|
5R01CA138586-02
|
$358,940
|
$358,940
|
Hata, Nobuhiko
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
A new paradigm for antibody-directed conjugates
|
1R43CA159720-01
|
$199,122
|
$39,824
|
Prudent, James
|
CENTROSE, LLC
|
|
A novel combination therapy for the treatment of Pancreatic adenocarcinoma
|
1R03CA149857-01A1
|
$74,250
|
$74,250
|
HOLLINGSWORTH, MICHAEL
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
A Novel ROS Controlling Kinase
|
5R21CA135164-02
|
$167,857
|
$167,857
|
FRIEDMAN, EILEEN
|
UPSTATE MEDICAL UNIVERSITY
|
|
A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese
|
5R01CA121023-05
|
$504,845
|
$504,845
|
WANG, JUDY
|
GEORGETOWN UNIVERSITY
|
|
A pooled analysis of risk factors of small intestine cancer
|
5R03CA150038-02
|
$85,360
|
$85,360
|
POTTER, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A Prospective Study of Colorectal Cancer: One-Carbon Metabolism and Inflammation
|
5R01CA120523-04
|
$605,656
|
$605,656
|
ULRICH, CORNELIA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A Randomized Trial of Hep B Screening and Vaccination in High Risk Vietnamese
|
5R01CA129763-05
|
$1
|
$1
|
MA, GRACE
|
TEMPLE UNIVERSITY
|
|
A Risk Prediction Model for Colorectal Cancer Screening
|
5R01CA131197-04
|
$391,087
|
$391,087
|
SCHROY, PAUL
|
BOSTON MEDICAL CENTER
|
|
A Study of the Prevalence of Esophageal Squamous Dysplasia in Western Kenya: the
|
ZIA CP000185-10575
|
$80,543
|
$80,543
|
Dawsey, Sanford
|
DCEG (NCI)
|
|
A Sustainable Approach to Increasing Cancer Screening in Community Health Centers
|
5R01CA126596-05
|
$535,151
|
$181,951
|
EMMONS, KAREN
|
DANA-FARBER CANCER INSTITUTE
|
|
A Systems Genetics Analysis of Cancer Risk, Progression and Therapeutic Response
|
5U01CA084244-13
|
$827,538
|
$165,508
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
A Tumor Suppressor Function for the c-Fes Tyrosine Kinase in Colon Cancer
|
5R01CA123756-04
|
$252,122
|
$252,122
|
SMITHGALL, THOMAS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
A Web-based Multimedia Intervention for Head and Neck Cancer Patients
|
1R41CA144100-01A1
|
$356,981
|
$356,981
|
FANG, CAROLYN
|
TRIAD INTERACTIVE, INC.
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
3U54CA153499-01S1
|
$41,909
|
$10,477
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
3U54CA153499-02S1
|
$44,987
|
$11,247
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
3U54CA153499-02S2
|
$63,611
|
$15,903
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
5U54CA153499-02
|
$1,015,404
|
$253,851
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,178,242
|
$58,912
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Aberrant DNA Methylation of MicroRNA Genes in Hepatocellular Carcinoma (HCC)
|
1R03CA156629-01A1
|
$80,000
|
$80,000
|
Shen, Jing
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Aberrant Glycosylation Signature in Pancreatic Cancer
|
1R21CA149772-01A1
|
$188,000
|
$188,000
|
Pan, Sheng
|
UNIVERSITY OF WASHINGTON
|
|
Academic Training in Medical Oncology
|
3T32CA009297-28S1
|
$66,919
|
$16,730
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Academic Training in Medical Oncology
|
5T32CA009297-28
|
$316,308
|
$79,077
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Academic-Industrial Partnership to Develop & Test Esophageal Cancer Imaging Tools
|
5R01CA140257-02
|
$580,206
|
$580,206
|
Richards-Kortum, Rebecca
|
RICE UNIVERSITY
|
|
Accurate, High Resolution 3D Dosimetry
|
5R01CA100835-08
|
$278,725
|
$139,363
|
OLDHAM, MARK
|
DUKE UNIVERSITY
|
|
ACOSOG Central Specimen Bank
|
3U24CA114736-05S2
|
$167,529
|
$67,012
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
ACOSOG Community Clinical Oncology Program (CCOP) Research Base
|
1U10CA149950-01A1
|
$1,300,000
|
$299,000
|
SLOAN, JEFF
|
MAYO CLINIC
|
|
ACOSOG Competing Renewal
|
2U10CA076001-15
|
$2,940,780
|
$735,195
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
ACOSOG Competing Renewal
|
3U10CA076001-15S1
|
$1,198,072
|
$299,518
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
ACTIVIN SIGNALING AND REGULATION IN THE COLON
|
5R01CA141057-02
|
$276,251
|
$276,251
|
JUNG, BARBARA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
ADAM17 in pancreatic cancer and pancreatitis
|
1R01CA159222-01
|
$395,872
|
$395,872
|
CRAWFORD, HOWARD
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Adding Hispanics to Ongoing GWAS in Colorectal Cancer
|
1R01CA155101-01A1
|
$949,873
|
$949,873
|
Figueiredo, Jane
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,298,263
|
$129,826
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Advanced Development of a Multiplexed SERS-based Biomarker Detection Platform: A
|
1R33CA155586-01A1
|
$340,860
|
$340,860
|
Porter, Marc
|
UNIVERSITY OF UTAH
|
|
Advanced glycation end products and colorectal cancer risk in women
|
1R03CA156626-01
|
|
$0
|
JIAO, LI
|
BAYLOR COLLEGE OF MEDICINE
|
Total relevant funding to Digestive Diseases for this search: $464,562,457
|